Medicine and Dentistry
Childhood Cancer
100%
Differentiated Thyroid Cancer
51%
Late Effect
30%
Pediatrics
30%
Ganglioneuroblastoma
28%
Adolescence
28%
Intracranial Tumor
27%
Iodine 131
25%
Thyroid Gland
24%
Prevalence
24%
(3 Iodobenzyl)guanidine
24%
Systematic Review
23%
Cancer in Young Adults
23%
Radiation Therapy
22%
Neoplasm
22%
Craniopharyngioma
19%
Fertility Preservation
19%
Malignant Neoplasm
18%
Thyroid Disease
17%
Thyroxine
16%
Endocrine Disease
16%
Thyroid Cancer
16%
Health Outcomes
14%
Body Mass Index
14%
Disease
13%
Quality of Life
13%
Chemotherapy
12%
Thyrotropin
12%
Bone Density
12%
Cohort Analysis
11%
Hypothyroidism
11%
Diagnosis
10%
Growth Hormone Deficiency
10%
Thyroid Function
10%
Cross Sectional Study
10%
Adverse Event
10%
Growth Hormone
9%
Radioactive Iodine
9%
Primary Ovarian Insufficiency
9%
Multiple Endocrine Neoplasia Type 2b
8%
Thyroid Medullary Carcinoma
8%
Potassium Iodide
7%
Neck
7%
Cancer Therapy
7%
(3 Iodobenzyl)guanidine I 131
7%
Multiple Endocrine Neoplasia
7%
Diabetes Insipidus
7%
Papillary Thyroid Cancer
7%
Odds Ratio
7%
Ganglioglioma
6%
Keyphrases
Childhood Cancer Survivors
65%
Survivors
57%
Childhood Cancer
35%
Differentiated Thyroid Carcinoma
31%
Dutch
29%
Neuroblastoma
28%
Risk Factors
27%
Late Effects
24%
Hypothalamic Obesity
23%
Craniopharyngioma
22%
Pediatric Thyroid Carcinoma
22%
Hypothalamic-pituitary Axis
19%
Cancer Guidelines
18%
Adult Cancer
18%
Thyroid Dysfunction
18%
131I-metaiodobenzylguanidine
16%
Thyroid Gland
16%
Endocrine Disorders
16%
Childhood Brain Tumor Survivors
15%
Radiotherapy
15%
Differentiated Thyroid Cancer
15%
Working Diagnosis
15%
Fertility Preservation
14%
Long-term Survivors
13%
Hypothalamic-pituitary Dysfunction
13%
Thyroid Cancer
12%
Multiple Endocrine Neoplasia Type 2 (MEN2)
11%
Pituitary Dysfunction
11%
Adult Survivors
11%
Netherlands
10%
Body Mass Index
10%
Thyroid Function
10%
Chemotherapy
10%
Thyroid Hormones
10%
Thyroxine
10%
123I-MIBG
9%
Quality of Survival
9%
Congenital Hypothyroidism
9%
Health Outcomes
9%
Childhood-onset
8%
Quality of Life
8%
131I-MIBG
8%
Free Thyroxine
8%
Pediatric Craniopharyngioma
8%
Potassium Iodide
8%
Growth Hormone Treatment
8%
Bone Mineral Density
8%
Childhood Cancer Survivor Study
8%
Brain Tumor
8%
Prevalence Risk
8%